Antibody-based therapeutics are promising for treating central nervous system (CNS) diseases; however, brain delivery is severely restricted by the blood-brain barrier (BBB). Intranasal administration has gained attention as a noninvasive route proposed to red... ...

请注册登录后继续浏览